Veterinary World

     Open access and peer reviewed journal  

ISSN (Online): 2231-0916

 

Home l Editorial board l Instructions for authors l Reviewer guideline l Open access policy l Archives l FAQ


Open Access


Research (Published online: 16-12-2016)

15. Intravenous administration of puppy deciduous teeth stem cells in degenerative valve disease - Soontaree Petchdee and Sarunya Sompeewong

Veterinary World, 9(12): 1429-1434

 

 

   doi: 10.14202/vetworld.2016.1429-1434

 

Soontaree Petchdee: Department of Large Animal and Wildlife Clinical Science, Faculty of Veterinary Medicine, Kasetsart University, Kamphaengsaen, Nakhorn Pathom 73140, Thailand; fvetstr@ku.ac.th

Sarunya Sompeewong: Kasetsart University, Veterinary Teaching Animal Hospital, Kamphaeng Saen, Thailand; lksarunya@gmail.com

 

Received: 23-07-2016, Accepted: 16-11-2016, Published online: 16-12-2016

 

Corresponding author: Soontaree Petchdee, e-mail: fvetstr@ku.ac.th


Citation: Petchdee S, Sompeewong S (2016) Intravenous administration of puppy deciduous teeth stem cells in degenerative valve disease, Veterinary World, 9(12): 1429-1434.



Aim: The objective of this study is to investigate the improvement of heart function in dogs with chronic valvular heart disease after puppy deciduous teeth stem cells (pDSCs) administration.

Materials and Methods: 20 client-owned dogs with degenerative valvular heart disease underwent multiple intravenous injections of allogeneic pDSCs. Dogs were randomly assigned to two groups: (i) Control group (n=10) with standard treatment for heart failure and (ii) group with standard treatment and multiple administrations of pDSCs (n=10). Electrocardiography, complete transthoracic echocardiography, thoracic radiography, and blood pressure were recorded before and after pDSCs injections for 15, 30 and 60 days.

Results: Post pDSCs injection showed measurable improvement in left ventricular ejection fraction, American College of Veterinary Internal Medicine (ACVIM) functional class significantly improved and improved quality of life scores were observed. In the control group, there were no significant enhancements in heart function or ACVIM class.

Conclusions: This finding suggests that pDSCs could be a supplement for valvular heart disease treatment.

Keywords: dental pulp stem cells, dogs, heart failure.



1. Stepien, R. (2015) Chronic valvular disease in dogs. Vet. Focus, 25: 3-13.
https://doi.org/10.1055/s-0034-1381935
 
2. Tarnow, I., Kristensen, A.T., Texel, H., Olsen, L.H. and Pedersen, H.D. (2003) Decreased platelet function in King Charles Spanials with mitral valve regurgitation. J. Vet. Intern. Med., 17: 680-686.
https://doi.org/10.1111/j.1939-1676.2003.tb02500.x
PMid:14529135
 
3. MacDonald, K.A., Kittleson, M.D., Munro, C. and Kass, P. (2003) Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure. J. Vet. Intern. Med., 17: 172-177.
https://doi.org/10.1111/j.1939-1676.2003.tb02430.x
PMid:12683617
 
4. Quellet, M., Belanger, M.C., DiFruscia, R. and Beauchamp, G. (2009) Effect of pimobendan on echocardiographic values in dogs with asymptomatic mitral valve disease. J. Vet. Intern. Med., 23: 258-263.
https://doi.org/10.1111/j.1939-1676.2008.0239.x
PMid:19143935
 
5. Brehm, M., Zeus, T. and Strauer, B.E. (2002) Stem cells; Clinical application and perspectives. Herz, 27: 611-620.
https://doi.org/10.1007/s00059-002-2435-y
PMid:12439633
 
6. Caspi, O. and Gepstein, L. (2006) Regenerating the heart using human embryonic stem cells from cell to bedside. Isr. Med. Assoc. J., 8: 208-214.
PMid:16599061
 
7. Kusindarta, D.L., Wihadmadyatami, H., Fibrianto, Y.H., Nugroho, W.S., Susetya, H., Musana, D.K., Wijayanto, H., Prihatna, S.A. and Wahyuni, A.E.T. (2016) Human umbilical mesenchymal stem cells conditioned medium promote primary wound healing regeneration. Vet. World, 9: 605-610.
https://doi.org/10.14202/vetworld.2016.605-610
PMid:27397984 PMCid:PMC4937052
 
8. Kang, B.J., Ryu, H.H., Park, S.S., Koyama, Y., Kikuchi, M., Woo, H.M., Kim, W.H. and Kweon. O.K. (2012) Comparing the osteogenic potential of canine mesenchymal stem cells derived from adipose tissues, bone marrow, umbilical cord blood, and Wharton's jelly for treating bone defects. J. Vet. Sci., 13: 299-310.
https://doi.org/10.4142/jvs.2012.13.3.299
PMid:23000587 PMCid:PMC3467406
 
9. Fuchs, S., Kornowski, R., Weisz, G., Satler, L.F., Smits, P.C., Okubagzi, P., Baffour, R., Aggarwal, A., Weissman, N.J., Cerqueira, M., Waksman, R., Serrruys, P., Battler, A., Moses, J.W., Leon, M.B. and Epstein, S.E. (2006) Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am. J. Cardiol., 97: 823-829.
https://doi.org/10.1016/j.amjcard.2005.09.132
PMid:16516583
 
10. Fuchs, S., Baffour, R., Zhou, Y.F., Shou, M., Pierre, A. and Tio, F.O. (2001) Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J. Am. Coll. Cardiol., 37(6): 1726-1732.
https://doi.org/10.1016/S0735-1097(01)01200-1
 
11. Wollert, K.C. and Drexler, H. (2005) Clinical applications of stem cells for the heart. Circ. Res., 96: 151-163.
https://doi.org/10.1161/01.RES.0000155333.69009.63
PMid:15692093
 
12. Bartolucci, J., Verdugo, F., Larrea, R., Carrion, F., Lamich, R., Pedreros, P., Delgado, M., Sanhueza, P., Khoury, M. and Figueroa, F. (2014) Stem cells for the treatment of cardiovascular diseases. An update. Rev. Med. Chil., 142: 1034-1046.
https://doi.org/10.4067/S0034-98872014000800011
PMid:25424676
 
13. Tomita, S., Li, R.K., Weisel, R.D., Mickle, D.A., Kim, E.J., Sakai, T. and Jia, Z.Q. (1991) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation, 100: 247-256.
 
14. Huang, G.T., Gronthos, S. and Shi, S. (2009) Mesenchymal stem cells derived from dental tissues vs. Those from other sources: Their biology and role in regenerative medicine. J. Dent. Res., 88: 792-806.
https://doi.org/10.1177/0022034509340867
 
15. Iohara, K., Zhenh, L., Wake, H., Ito, M., Nabekura, J., Wakita, H., Nakamura, H., Into, T., Matsushita, K. and Nakashima, M. (2008) A novel stem cells source for vasculogenesis in ischemia: Subfraction of side population cells from dental pulp. Stem Cell, 26: 2408-2418.
https://doi.org/10.1634/stemcells.2008-0393
PMid:18583536
 
16. Williams, A.R. and Hare, J.M. (2011) Mesenchymal stem cells: Biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ. Res., 109(8): 923-940.
https://doi.org/10.1161/CIRCRESAHA.111.243147
PMid:21960725 PMCid:PMC3604746
 
17. Kashyap, R. (2015) SHED-basic structure for stem cells research. J. Clin. Diagn. Res., 9: ZE07-ZE09.
https://doi.org/10.7860/jcdr/2015/9871.5636
 
18. Bootcha, R., Temvijitr, J. and Petchdee, S. (2015) Intra-articular injections with allogenic dental pulp stem cells for chronic osteoarthritis. Thai J. Vet. Med., 45: 131-139.
 
19. Petchdee, S., Pattanapon, N., Bootcha, R., Srivattanakul, P. and Songserm, T. (2014) Dental tissue-derived stem cells exerts therapeutic effects on chronic myocardial infarction model of rabbit. Cardiology, 9: 1-6.
 
20. Atkins, C., Bonagura, J. and Ettinger, S. (2009) Guildlines for diagnosis and treatment of canine chronic valvular heart disease. J. Vet. Intern. Med., 23: 1142-1150.
https://doi.org/10.1111/j.1939-1676.2009.0392.x
PMid:19780929
 
21. Meluzin, J., Mayer, J. and Groch, L. (2006) Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial function. Am. Heart J., 152(5): 975-979.
https://doi.org/10.1016/j.ahj.2006.08.004
 
22. Imanishi, Y., Saito, A., Komoda, H., Kitagawa-Sakakida, S., Miyagawa, S. and Kondoh, H. (2008) Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. J. Mol. Cell. Cardiol., 44: 662-671.
https://doi.org/10.1016/j.yjmcc.2007.11.001
PMid:18343403
 
23. Gnecchi, M., Zhang, Z., Ni, A. and Dzau, V.J. (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res., 103(11): 1204-1219.
https://doi.org/10.1161/CIRCRESAHA.108.176826
PMid:19028920 PMCid:PMC2667788
 
24. van der Bogt, K.E., Schrepfer, S., Yu, J., Sheikh, A.Y., Hoyt, G., Govaert, J.A., Velotta, J.B., Contag, C.H., Robbins, R.C. and Wu, J.C. (2009) Comparison of transplantation of adipose tissue and bone marrow derived mesenchymal stem cells in the infarcted heart. Transplantation, 87: 642-652.
https://doi.org/10.1097/TP.0b013e31819609d9
PMid:19295307 PMCid:PMC2866004
 
25. Yang, J.J., Liu, Z.Q., Zhang, J.M., Wang, H.B., Hu, S.Y., Liu, J.F., Wang, C.Y. and Chen, Y.D. (2013) Real-time tracking of adipose tissue-derived stem cells with injectable scaffolds in the infarcted heart. Heart Vessels, 28(3): 385-396.
https://doi.org/10.1007/s00380-012-0275-0
PMid:22940832
 
26. Huang, S.J. and McLean, A.S. (2012) Appreciating the strengths and weakness of transthoracic echocardiography in hemodynamic assessments. Cardiol. Res. Pract., 2012: 1-7.
https://doi.org/10.1155/2012/894308
PMid:22454777 PMCid:PMC3290825
 
27. Yao, Y., Huang, J. and Geng, Y. (2015) Paracrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine hearts. PLoS One, 10(6): e0129164.
https://doi.org/10.1371/journal.pone.0129164
 
28. Scipio, F., Sprio, A., Folino, A., Cerere, E.M., Salamone, P., Yang, Z., Berrone, M., Prat, M., Losano, G., Rastaldo, R. and Berta, G.N. (2014) Cardiomyocytes promote dental pulp mesenchymal stem cell homing. Biochim. Biophys. Acta, 1840: 2152-2161.
https://doi.org/10.1016/j.bbagen.2014.03.005
PMid:24631652
 
29. Chimenti, I., Smith, R.R., Li, T.S., Gerstenblith, G., Messina, E. and Giacomello, A. (2010) Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res., 106(5): 971-980.
https://doi.org/10.1161/CIRCRESAHA.109.210682
PMid:20110532 PMCid:PMC4317351
 
30. Torre-Amione, G. (2005) Immune activation in chronic heart failure. Am. J. Cardiol., 95(11A): 3C-8C.
https://doi.org/10.1016/j.amjcard.2005.03.006
PMid:15925558
 
31. Menasche, P. (2009) Stem cell therapy for heart failure: Are arrhythmias a real safety concern? Circulation, 119: 2735-2740.
https://doi.org/10.1161/CIRCULATIONAHA.108.812693
PMid:19470902
 
32. Molina, E.J., Palma, J., Gupta, D., Torres, D., Gaughan, J.P. and Houser, S. (2008) Improvement in hemodynamic performance, exercise capacity, inflammatory profile, and left ventricular reverse remodeling after intracoronary delivery of mesenchymal stem cells in an experimental model of pressure overload hypertrophy. J. Thorac. Cardiovasc. Surg., 135(2): 292-299, 299.e1.